http://www.unboundmedicine.com/medline/ebm/research/ReminylUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19047474/full_citation/Efficacy_of_a_Vitamin/Nutriceutical_Formulation_for_Early_stage_Alzheimer's_Disease:_A_1_Year_Open_Label_Pilot_Study_With_an_16_Month_Caregiver_Extension_Chan A, Paskavitz J, Remington R, et al. 
Efficacy of a Vitamin/Nutriceutical Formulation for Early-stage Alzheimer's Disease: A 1-Year, Open-Label Pilot Study With an 16-Month Caregiver Extension. [JOURNAL ARTICLE]
Am J Alzheimers Dis Other Demen 2008 Dec 1.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19042161/full_citation/Safety_and_efficacy_of_galantamine__Reminyl__in_severe_Alzheimer's_disease__the_SERAD_study_:_a_randomised_placebo_controlled_double_blind_trial_Burns A, Bernabei R, Bullock R, et al. 
Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial. [JOURNAL ARTICLE]
Lancet Neurol 2008 Nov 28.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19042160/full_citation/The_SERAD_study_of_the_safety_and_efficacy_of_galantamine_in_severe_Alzheimer's_disease_Farlow MR 
The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease. [LETTER]
Lancet Neurol 2008 Nov 28.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19032118/full_citation/Importance_of_circadian_rhythmicity_in_the_cholinergic_treatment_of_Alzheimer's_disease:_focus_on_galantamine___Nieoullon A, Bentué-Ferrer D, Bordet R, et al. 
Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine *. [Journal Article]
Curr Med Res Opin 2008 Dec; 24(12):3357-67.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19032006/full_citation/Rivastigmine_transdermal_patch:_role_in_the_management_of_Alzheimer's_disease_Guay DR 
Rivastigmine transdermal patch: role in the management of Alzheimer's disease. [Journal Article]
Consult Pharm 2008 Aug; 23(8):598-609.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19021024/full_citation/Vesicular_Acetylcholine_Transporter__VAChT__in_the_Brain_of_Spontaneously_Hypertensive_Rats__SHR_:_Effect_of_Treatment_with_an_Acetylcholinesterase_Inhibitor_Tayebati SK, Di Tullio MA, Amenta F 
Vesicular Acetylcholine Transporter (VAChT) in the Brain of Spontaneously Hypertensive Rats (SHR): Effect of Treatment with an Acetylcholinesterase Inhibitor. [JOURNAL ARTICLE]
Clin Exp Hypertens 2008 Nov; 30(8):732-743.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19008069/full_citation/[Bradycardia_induced_by_galantamine_]Leclerc C, Genuit-Leclerc L, Citerne O 
[Bradycardia induced by galantamine.] [JOURNAL ARTICLE]
Ann Fr Anesth Reanim 2008 Nov 12.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18991634/full_citation/The_therapeutical_potential_of_alpha_synuclein_antiaggregatory_agents_for_dementia_with_lewy_bodies_Beyer K, Ariza A 
The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with lewy bodies. [Journal Article]
Curr Med Chem 2008; 15(26):2748-59.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18991117/full_citation/Combined_models_for_data_from_in_vitro_in_vivo_correlation_experiments_Jacobs T, Rossenu S, Dunne A, et al. 
Combined models for data from in vitro-in vivo correlation experiments. [Journal Article, Research Support, Non-U.S. Gov't]
J Biopharm Stat 2008; 18(6):1197-211.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18985627/full_citation/Treatment_with_galantamine_and_time_to_nursing_home_placement_in_Alzheimer's_disease_patients_with_and_without_cerebrovascular_disease_Feldman HH, Pirttila T, Dartigues JF, et al. 
Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease. [JOURNAL ARTICLE]
Int J Geriatr Psychiatry 2008 Nov 4.
Abstract | Full Citation | Find Related Articles